Massonnaud CR, Peiffer-Smadja N, Poignard P, Jamard S, Goehringer F, Danion F, Reignier J, de Castro N, Garot D, Lapique EL, Lacombe K, Tolsma V, Faure E, Malvy D, Staub T, Courjon J, Cazenave-Roblot F, Dyrhol Riise AM, Leturnier P, Martin-Blondel G, Roger C, Akinosoglou K, Vincent Le Moing, Piroth L, Sellier Pet al.(2025) Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial Clin Microbiol Infect(in press) DOI 10.1016/j.cmi.2025.12.014, PubMed 41429349
Tunheim G, Baranowska-Hustad M, Lund-Johansen F, Fossum E, Bhandari S, Kukule L, Møller TKR, Vikse EL, Bekkevold T, Oftung F, Robertson AH, Næss LM(2025) SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway APMIS, 133(12), e70102 DOI 10.1111/apm.70102, PubMed 41376258
Stenlander C, Lindahl H, Wahren-Borgström E, Geier CB, Sediva A, Fevang B, Milito C, Varandas C, Roca-Oporto C, Pulvirenti F, Hodl I, Malkusova I, Rivière JG, Litzman J, Walter JE, Hanitsch LG, Neth O, Kralickova P, Miller R, Shaffren S, Silva SL, Katzenstein T, Martelius T, Steiner UC, Smith CIEet al.(2025) Bronchiectasis, Low IgG Levels and Lack of Vaccination are Risk Factors for Covid-19 Hospitalization in X-linked Agammaglobulinemia - A Retrospective Multicenter Study J Clin Immunol, 45(1), 161 DOI 10.1007/s10875-025-01962-3, PubMed 41240154
